BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine
Released Thursday, 4th April 2024
Good episode? Give it some love!
BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine
BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine
Thursday, 4th April 2024
Good episode? Give it some love!
Rate Episode
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that casts doubt on the future of BTK inhibitors for MS, an assessment of the cost-effectiveness of lecanemab, and findings that COVID vaccines are not significantly associated with adverse neurologic events.
Show More
Rate
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Episode Tags
Do you host or manage this podcast?
Claim and edit this page to your liking.
,Claim and edit this page to your liking.
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us